Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses (Q35055183)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses (English)

1 reference

Europe PubMed Central

6 August 2017

Jaranit Kaewkungwal

object named as

Jaranit Kaewkungwal

20

0 references

object named as

Guido Ferrari

26

0 references

David C. Montefiori

25

object named as

David C Montefiori

1 reference

Europe PubMed Central

6 August 2017

24

object named as

Barton F Haynes

1 reference

Europe PubMed Central

6 August 2017

18

object named as

Merlin Robb

1 reference

Europe PubMed Central

6 August 2017

17

object named as

Nelson L Michael

1 reference

Europe PubMed Central

6 August 2017

16

object named as

Jerome H Kim

1 reference

Europe PubMed Central

6 August 2017

Supachai Rerks-Ngarm

22

object named as

Supachai Rerks-Ngarm

1 reference

Europe PubMed Central

6 August 2017

Georgia D. Tomaras

27

object named as

Georgia D Tomaras

1 reference

Europe PubMed Central

6 August 2017

13

object named as

Nicole L Yates

1 reference

Europe PubMed Central

6 August 2017

Coleen K. Cunningham

2

object named as

Coleen K Cunningham

1 reference

Europe PubMed Central

6 August 2017

Petronella Muresan

5

object named as

Petronella Muresan

1 reference

Europe PubMed Central

6 August 2017

Elizabeth J. McFarland

3

object named as

Elizabeth J McFarland

1 reference

Europe PubMed Central

6 August 2017

Sorachai Nitayaphan

21

object named as

Sorachai Nitayaphan

1 reference

Europe PubMed Central

6 August 2017

Punnee Pitisuttithum

19

object named as

Punnee Pitisuttithum

1 reference

Europe PubMed Central

6 August 2017

6

object named as

Justin Pollara

1 reference

Europe PubMed Central

6 August 2017

M Anthony Moody

14

object named as

M Anthony Moody

1 reference

Europe PubMed Central

6 August 2017

Nathan Vandergrift

11

object named as

Nathan A Vandergrift

1 reference

Europe PubMed Central

6 August 2017

R Glenn Overman

12

object named as

R Glenn Overman

1 reference

Europe PubMed Central

6 August 2017

Sallie R Permar

28

object named as

Sallie R Permar

1 reference

Europe PubMed Central

6 August 2017

23

object named as

Hua-Xin Liao

1 reference

Europe PubMed Central

6 August 2017

Genevieve G Fouda

1

object named as

Genevieve G Fouda

1 reference

Europe PubMed Central

6 August 2017

8

object named as

Brooke E Liebl

1 reference

Europe PubMed Central

6 August 2017

Kaylan Whitaker

9

object named as

Kaylan Whitaker

1 reference

Europe PubMed Central

6 August 2017

author name string

William Borkowsky

4

1 reference

Europe PubMed Central

6 August 2017

Lin Ye Song

7

1 reference

Europe PubMed Central

6 August 2017

Xiaoying Shen

10

1 reference

Europe PubMed Central

6 August 2017

Carrie Fry

15

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

27 August 2014

1 reference

Europe PubMed Central

6 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

6 August 2017

211

1 reference

Europe PubMed Central

6 August 2017

508-517

1 reference

Europe PubMed Central

6 August 2017

4

1 reference

Europe PubMed Central

6 August 2017

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

HIV vaccines: lessons learned and the way forward

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Measuring HIV neutralization in a luciferase reporter gene assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

The challenges of vaccine responses in early life: selected examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

8 July 2018

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU444

21 January 2018

Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU444

21 January 2018

Immunogenicity of the pentavalent rotavirus vaccine in African infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318918

25 October 2018

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU444

21 January 2018

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25170104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIU444

1 reference

Europe PubMed Central

6 August 2017

release_2nob4r7duzh47fmo2l74nlruyu

1 reference

https://api.fatcat.wiki/v0/release/2nob4r7duzh47fmo2l74nlruyu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35055183&oldid=2118919367"